BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15878248)

  • 1. Serial MR imaging and 1H-MR spectroscopy of unidentified bright objects in a case of neurofibromatosis type 1.
    Imamura A; Matsuo N; Okuda M; Morita H; Iwata M; Yamazaki Y; Takahashi Y
    Brain Dev; 2005 Dec; 27(8):595-7. PubMed ID: 15878248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging.
    Wang PY; Kaufmann WE; Koth CW; Denckla MB; Barker PB
    Ann Neurol; 2000 Apr; 47(4):477-84. PubMed ID: 10762159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial brain imaging analysis of stroke-like episodes in MELAS.
    Ito H; Mori K; Harada M; Minato M; Naito E; Takeuchi M; Kuroda Y; Kagami S
    Brain Dev; 2008 Aug; 30(7):483-8. PubMed ID: 18289816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging and 1H-MR spectroscopy in a case of cerebral infarction with transient cerebral arteriopathy.
    Imamura A; Matsuo N; Ariki M; Horikoshi H; Hattori T
    Brain Dev; 2004 Dec; 26(8):535-8. PubMed ID: 15533656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial MR imaging and 1H-MR spectroscopy in monozygotic twins with Tay-Sachs disease.
    Imamura A; Miyajima H; Ito R; Orii KO
    Neuropediatrics; 2008 Oct; 39(5):259-63. PubMed ID: 19294598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: correlation with T2 hyperintensities.
    Barbier C; Chabernaud C; Barantin L; Bertrand P; Sembely C; Sirinelli D; Castelnau P; Cottier JP
    Neuroradiology; 2011 Feb; 53(2):141-8. PubMed ID: 20959972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1: diffusion weighted imaging findings of brain.
    Alkan A; Sigirci A; Kutlu R; Ozcan H; Erdem G; Aslan M; Ates O; Yakinci C; Egri M
    Eur J Radiol; 2005 Nov; 56(2):229-34. PubMed ID: 15963674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.
    Villanueva V; Alvarez-Linera J; Gómez-Garre P; Gutiérrez J; Serratosa JM
    Epilepsia; 2006 Apr; 47(4):788-92. PubMed ID: 16650146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings.
    Kim EA; Cheong HK; Choi DS; Sakong J; Ryoo JW; Park I; Kang DM
    Neurotoxicology; 2007 Mar; 28(2):276-83. PubMed ID: 16824604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal evolution of unidentified bright objects in children with neurofibromatosis-1.
    Kraut MA; Gerring JP; Cooper KL; Thompson RE; Denckla MB; Kaufmann WE
    Am J Med Genet A; 2004 Aug; 129A(2):113-9. PubMed ID: 15316979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
    Arana E; Martínez-Granados B; Marti-Bonmati L; Martínez-Bisbal MC; Gil A; Blasco C; Celda B
    Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential?
    Griffiths PD; Blaser S; Mukonoweshuro W; Armstrong D; Milo-Mason G; Cheung S
    Pediatrics; 1999 Oct; 104(4):e49. PubMed ID: 10506274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spontaneous regression of basal ganglia lesions in a case of neurofibromatosis type 1 (case report)].
    Oztürk M; Ozyazgan I; Mavili E; Orhan S
    Tani Girisim Radyol; 2003 Dec; 9(4):439-42. PubMed ID: 14730952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain stem tumors associated with neurofibromatosis type 1. Presentation of 20 infantile patients].
    Pascual Castroviejo I; Pascual Pascual S; Velázquez Fragua R; Viaño J; Garcia Segura JM
    Neurologia; 2007 Dec; 22(10):846-52. PubMed ID: 17671854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant cystic lesion in neurofibromatosis.
    Cohen R; Kornreich L; Shuper A
    Pediatr Neurol; 2009 Dec; 41(6):445-7. PubMed ID: 19931167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging and 1H-MR spectroscopy of a case of van der Knaap disease.
    Morita H; Imamura A; Matsuo N; Tatebayashi K; Omoya K; Takahashi Y; Tsujino S
    Brain Dev; 2006 Aug; 28(7):466-9. PubMed ID: 16504440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
    Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between 1H-MR spectroscopy and clinical manifestation with tuberous sclerosis complex.
    Matsuo N; Imamura A; Ito R; Sugawara K; Takahashi Y; Kondo N
    Neuropediatrics; 2007 Jun; 38(3):126-9. PubMed ID: 17985261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.